Biohit Signs Licencing Agreement With Randox

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Finnish healthcare company Biohit Oyj and Randox Laboratories have signed a licensing agreement which gives Randox the worldwide licensing rights for GastroPanel developed by Biohit. GastroPanel developed by Biohit is a simple, non-invasive blood test for the diagnosis and screening of gastric disorders.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC